Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: Assessment of feasibility and proof of concept study for microvascular reactivity in anesthetized cats.
Methods: 12, adult, healthy, purpose-bred cats were included. Cats were anesthetized and instrumented with a perivascular ultrasound transit time flow probe around the main pulmonary artery, a femoral arterial catheter, a central venous catheter, and a laser Doppler flowmeter with a heating unit. After a 20-minute stabilization period, microvascular reactivity, hemodynamic variables, and arterial and central venous blood gases were measured during 3 phases: (1) baseline, (2) hemorrhage, and (3) isotonic crystalloid bolus. Hemorrhage was induced by atraumatic blood loss of 20 mL/kg over 20 minutes. An isotonic crystalloid bolus at 20 mL/kg was administered IV over 20 minutes.
Results: 6 cats were excluded from the analysis due to equipment errors or surgical complications. Microvascular reactivity decreased significantly after hemorrhage and remained below baseline after isotonic crystalloid bolus.
Conclusions: Microvascular reactivity assessment is feasible in healthy anesthetized cats. Hemorrhage decreases microvascular reactivity, and the administration of an isotonic crystalloid bolus did not reverse these changes. However, the small sample size may limit the external validity of the results.
Clinical Relevance: This study demonstrated the feasibility of microvascular reactivity assessment in anesthetized cats. However, proper validation is warranted before clinical application.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2460/ajvr.24.09.0262 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Introduction: Endothelial dysfunction has been reported in rheumatoid arthritis (RA) patients without classical cardiovascular risk factors, but findings remain inconsistent.
Objectives: To assess whether endothelial function is impaired in RA with moderate inflammatory burden in the absence of established cardiovascular risk factors.
Patients And Methods: This cross-sectional study was conducted in 64 patients with RA without classical CV risk factors and 60 healthy age- and sex-matched controls.
Caspase-1 Activation Drives Vascular Inflammatory Processes and Hypoperfusion in Intravascular Hemolysis.
Am J Physiol Heart Circ Physiol
September 2025
Hematology and Transfusion Center, University of Campinas - UNICAMP, Campinas. São Paulo, Brazil. 13083-878.
Intravascular hemolysis (IVH), a pathological process associated with various conditions, triggers inflammatory responses, yet the key molecular drivers of these responses are poorly defined, particularly within the vasculature. To explore the role of NLRP3 inflammasome- and caspase-1-dependent pathways in IVH-induced vascular dysfunction, we used models of acute and chronic IVH, alongside heme stimulation of endothelial cells, thereby isolating this disease mechanism from its etiological causes. IVH induced rapid inflammatory responses in C57BL/6J mice, including IL-1β release within 15 minutes, and NLRP3-dependent caspase-1 activation in circulating leukocytes.
View Article and Find Full Text PDFQuercetin ameliorates renal injury by promoting UCP1-mediated alleviation of lipid accumulation in diabetic kidney disease.
Phytomedicine
August 2025
State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China. Electronic address:
Background: Diabetic kidney disease (DKD) represents a common microvascular complication associated with diabetes. Research suggests that lipid accumulation contributes to lipotoxicity, exacerbating kidney injury in DKD. Quercetin (QCT), a flavonoid derived from specific fruits and vegetables, has shown potential in mitigating DKD progression; however, its precise protective mechanisms remain to be explored.
View Article and Find Full Text PDFMicrovascular Function and Ambulatory Capacity in Peripheral Artery Disease.
Circ Cardiovasc Interv
September 2025
Division of Vascular Medicine, Department of Medicine (J.A.B.), The University of Texas Southwestern Medical Center, Dallas.
Background: Patients with peripheral artery disease experience walking impairment that is incompletely explained by large-artery atherosclerotic occlusive disease and abnormal ankle-brachial index (ABI). Microvascular dysfunction is associated with adverse outcomes, including amputation, but its effect on ambulation is unknown. We tested the hypothesis that skeletal muscle microvascular function directly associates with walking distance, is a more sensitive indicator of walking distance than conduit artery blood inflow, and correlates with ambulatory improvement following peripheral artery disease interventions.
View Article and Find Full Text PDFBenralizumab in a Patient With Refractory Eosinophilic Endocarditis.
J Med Cases
August 2025
Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA.
Hypereosinophilic syndrome (HES) is a hematologic disorder characterized by an increased absolute eosinophil count (AEC) that can lead to tissue infiltration and damage. Idiopathic HES (iHES) comprises a subset of patients with HES, in which a reactive cause such as infections or an inflammatory process cannot be identified, and clonality is not demonstrable. iHES remains a challenge to treat since there is no specific mutation to target.
View Article and Find Full Text PDF